Search Results | Cancer Research | American Association for Cancer Research

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Abstract 2710: Associations between structural variant signatures and drug sensitivity in cell lines

Simona Dalin, Frank Dubois, Shu Zhang, Alexander Crane, Jeremie Kalfon, Javad Noorbakhsh, Rameen Beroukhim

Cancer Res (2022) 82 (12_Supplement): 2710.

DOI: https://doi.org/10.1158/1538-7445.AM2022-2710

Published: 15 June 2022

View article

Journal Articles

Abstract 1682: Imaging mass cytometry reveals key spatial features among immune cells in hepatocellular carcinomas treated with neoadjuvant cabozantinib and nivolumab

Shu Zhang, Qingfeng Zhu, Nicole Gross, Soren Charmsaz, Atul Deshpande, Stephanie Xavier, Aditya Mohan, James Leatherman, Guanglan Mo, Jennifer Durham, Aleksandra Popovic, Brad Wilt, Dongxia Lin, Derek Quong, Robert Anders, Elana Fertig, Elizabeth M. Jaffee, Mark Yarchoan, Won J. Ho

Cancer Res (2021) 81 (13_Supplement): 1682.

DOI: https://doi.org/10.1158/1538-7445.AM2021-1682

Published: 01 July 2021

View article

Journal Articles

Abstract PD6-07: Volumetric changes on longitudinal dynamic contrast enhanced MR imaging (DCE-MRI) as an early treatment response predictor to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients

Cancer Res (2021) 81 (4_Supplement): PD6-07.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PD6-07

Published: 15 February 2021

View article

Journal Articles

Abstract PD6-06: Radiomic phenotypes from dynamic contrast-enhanced MRI (DCE-MRI) parametric maps for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients

Cancer Res (2021) 81 (4_Supplement): PD6-06.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PD6-06

Published: 15 February 2021

View article

Journal Articles

Abstract PS3-08: Assessment of early response to neoadjuvant systemic therapy (NAST) of triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: A pilot study

Cancer Res (2021) 81 (4_Supplement): PS3-08.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS3-08

Published: 15 February 2021

View article

Journal Articles

SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial–Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model

Meng Xu, Jingxiao Wang, Zhong Xu, Rong Li, Pan Wang, Runze Shang, Antonio Cigliano, Silvia Ribback, Antonio Solinas, Giovanni Mario Pes, Katja Evert, Haichuan Wang, Xinhua Song, Shu Zhang, Li Che, Rosa Maria Pascale, Diego Francesco Calvisi, Qingguang Liu, Xin Chen

Cancer Res (2019) 79 (21): 5563–5574.

DOI: https://doi.org/10.1158/0008-5472.CAN-18-3750

Published: 01 November 2019

View article

Includes: Supplementary data

Journal Articles

Abstract 1721: FOXO1, a downstream substrate of AKT, function as tumor suppressor in HCC carcinogenesis

Shu Zhang, Xin Chen

Cancer Res (2019) 79 (13_Supplement): 1721.

DOI: https://doi.org/10.1158/1538-7445.AM2019-1721

Published: 01 July 2019

View article

Journal Articles

MBD2 Ablation Impairs Lymphopoiesis and Impedes Progression and Maintenance of T-ALL

Mi Zhou, Kuangguo Zhou, Ling Cheng, Xing Chen, Jue Wang, Xiao-Min Wang, Yingchi Zhang, Qilin Yu, Shu Zhang, Di Wang, Liang Huang, Mei Huang, Ding Ma, Tao Cheng, Cong-Yi Wang, Weiping Yuan, Jianfeng Zhou

Cancer Res (2018) 78 (7): 1632–1642.

DOI: https://doi.org/10.1158/0008-5472.CAN-17-1434

Published: 01 April 2018

View article

Includes: Supplementary data

Journal Articles

Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation and Tumor Growth through the Histone H1.3-H19 Cascade

Dong Yang, Bin Sun, Xiaohong Zhang, Daomei Cheng, Xiaoping Yu, Lanzhen Yan, Lei Li, Sanqi An, Hua Jiang, Anna Lasorella, Antonio Iavarone, Shu Zhang, Fangdong Zou, Xudong Zhao

Cancer Res (2017) 77 (18): 4773–4784.

DOI: https://doi.org/10.1158/0008-5472.CAN-16-2597

Published: 14 September 2017

View article

Includes: Supplementary data

Journal Articles

Abstract 3564: Silencing pfkfb2 enhances paclitaxel sensitivity by modulating metabolism of p53 wt ovarian and breast cancer cells and xenografts

Hailing Yang, Shu Zhang, Weiqun Mao, Ahmed A. Ahmed, Nicholas B. Jennings, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Anil K. Sood, Xiao-Feng Le, Zhen Lu, Robert C. Bast

Cancer Res (2017) 77 (13_Supplement): 3564.

DOI: https://doi.org/10.1158/1538-7445.AM2017-3564

Published: 01 July 2017

View article

Journal Articles

Abstract 3032: A novel compound ARN-3236 inhibits SIK2 and sensitizes ovarian cancer to paclitaxel

Jinhua Zhou, Albandri Alfredi, Shu Zhang, Janice M. Santiago-O’Farrill, Ahmed A. Ahmed, Hailing Yang, Weiqun Mao, Yan Wang, Hariprasad Vankayalapati, Zhen Lu, Robert C. Bast, Jr

Cancer Res (2016) 76 (14_Supplement): 3032.

DOI: https://doi.org/10.1158/1538-7445.AM2016-3032

Published: 15 July 2016

View article

Journal Articles

Abstract 749: Highly potent and orally available SIK2 inhibitors block growth of human ovarian cancer cells in culture and xenografts

Albandri Alfredi, Shu Zhang, Weiqu Mao, Yan Wang, Hiroshi Takemori, Zhen Lu, Robert C. Bast, Hariprasad Vankayalapati

Cancer Res (2014) 74 (19_Supplement): 749.

DOI: https://doi.org/10.1158/1538-7445.AM2014-749

Published: 01 October 2014

View article

Journal Articles

Abstract 5433: Knockdown of the glycolytic enzyme PFKFB2 induces growth inhibition and enhances paclitaxel sensitivity in ovarian cancer cells.

Shu Zhang, Weiqun Mao, Anil K. Sood, Nicholas B. Jennings, Cristian Rodriguez-Aguayo, Gabriel Lopez-Berestein, Zong-Fang Li, Robert C. Bast, Xiao-Feng Le

Cancer Res (2013) 73 (8_Supplement): 5433.

DOI: https://doi.org/10.1158/1538-7445.AM2013-5433

Published: 15 April 2013

View article

Journal Articles

Abstract 3055: miR-495 functions as a novel regulator of the estrogen and progesterone receptorsin human breast cancers.

Xiao-Feng Le, Hui Ling, Maggie Mao, Xinna Zhang, Shu Zhang, George A. Calin, Yun Wu, Robert C. Bast

Cancer Res (2013) 73 (8_Supplement): 3055.

DOI: https://doi.org/10.1158/1538-7445.AM2013-3055

Published: 15 April 2013

View article

Journal Articles

Abstract 3057: CDK5 modulates the cell cycle, apoptosis and paclitaxel sensitivity in human ovarian cancer cells with wild-type p53 function

Shu Zhang, Weiqun Mao, Ahmed A. Ahmed, Zong-Fang Li, Xiao-Feng Le, Robert C. Bast, Jr

Cancer Res (2012) 72 (8_Supplement): 3057.

DOI: https://doi.org/10.1158/1538-7445.AM2012-3057

Published: 15 April 2012

View article

Journal Articles

Abstract 1216: The mechanism related to anti-apoptotic property of SOX2 in prostate cancer

Xianpei Jia, Xuefei Li, Wenjun Mou, Shu Zhang, Xiaoyue Tan, Cheng-Hu Liu, Rong Xiang, Na Li

Cancer Res (2010) 70 (8_Supplement): 1216.

DOI: https://doi.org/10.1158/1538-7445.AM10-1216

Published: 15 April 2010

View article

Journal Articles

Abstract #3593: Clinical and pharmacodynamic activity of decitabine in vivo for patients with recurrent, platinum-resistant, epithelial ovarian cancer

Fang Fang, Curt Balch, Jeanne Schilder, Shu Zhang, Changyu Shen, Lang Li, Anthony Snyder, Kenneth Nephew, Daniela Matei

Cancer Res (2009) 69 (9_Supplement): 3593.

Published: 01 May 2009

View article

Journal Articles

Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

Shu Zhang, Curt Balch, Michael W. Chan, Hung-Cheng Lai, Daniela Matei, Jeanne M. Schilder, Pearlly S. Yan, Tim H-M. Huang, Kenneth P. Nephew

Cancer Res (2008) 68 (11): 4311–4320.

DOI: https://doi.org/10.1158/0008-5472.CAN-08-0364

Published: 02 June 2008

View article

Includes: Supplementary data

Journal Articles

Aryl hydrocarbon receptor agonists inhibit breast cancer cell growth and modulate microRNA expression

Shu Zhang, Craig Rowlands, Stephen Safe

Cancer Res (2008) 68 (9_Supplement): 133.

Published: 01 May 2008

View article

Journal Articles

Identification and characterization of cancer stem-like cells from human ovarian carcinomas

Shu Zhang, Michael Chan, Curt Balch, Pearlly Yan, Dhaval Desai, John Montgomery, Tim Huang, Kenneth Nephew

Cancer Res (2007) 67 (9_Supplement): 239.

Published: 01 May 2007

View article

NARROW

Abstract 2710: Associations between structural variant signatures and drug sensitivity in cell lines

Abstract 1682: Imaging mass cytometry reveals key spatial features among immune cells in hepatocellular carcinomas treated with neoadjuvant cabozantinib and nivolumab

Abstract PD6-07: Volumetric changes on longitudinal dynamic contrast enhanced MR imaging (DCE-MRI) as an early treatment response predictor to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients

Abstract PD6-06: Radiomic phenotypes from dynamic contrast-enhanced MRI (DCE-MRI) parametric maps for early prediction of response to neoadjuvant systemic therapy (NAST) in triple negative breast cancer (TNBC) patients

Abstract PS3-08: Assessment of early response to neoadjuvant systemic therapy (NAST) of triple-negative breast cancer (TNBC) using chemical exchange saturation transfer (CEST) MRI: A pilot study

SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial–Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model

Abstract 1721: FOXO1, a downstream substrate of AKT, function as tumor suppressor in HCC carcinogenesis

MBD2 Ablation Impairs Lymphopoiesis and Impedes Progression and Maintenance of T-ALL

Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation and Tumor Growth through the Histone H1.3-H19 Cascade

Abstract 3564: Silencing pfkfb2 enhances paclitaxel sensitivity by modulating metabolism of p53 wt ovarian and breast cancer cells and xenografts

Abstract 3032: A novel compound ARN-3236 inhibits SIK2 and sensitizes ovarian cancer to paclitaxel

Abstract 749: Highly potent and orally available SIK2 inhibitors block growth of human ovarian cancer cells in culture and xenografts

Abstract 5433: Knockdown of the glycolytic enzyme PFKFB2 induces growth inhibition and enhances paclitaxel sensitivity in ovarian cancer cells.

Abstract 3055: miR-495 functions as a novel regulator of the estrogen and progesterone receptorsin human breast cancers.

Abstract 3057: CDK5 modulates the cell cycle, apoptosis and paclitaxel sensitivity in human ovarian cancer cells with wild-type p53 function

Abstract 1216: The mechanism related to anti-apoptotic property of SOX2 in prostate cancer

Abstract #3593: Clinical and pharmacodynamic activity of decitabine in vivo for patients with recurrent, platinum-resistant, epithelial ovarian cancer

Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors

Aryl hydrocarbon receptor agonists inhibit breast cancer cell growth and modulate microRNA expression

Identification and characterization of cancer stem-like cells from human ovarian carcinomas

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only